Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-6bf8c574d5-9f2xs Total loading time: 0 Render date: 2025-03-05T19:40:17.298Z Has data issue: false hasContentIssue false

Chapter 10 - Neuro-Ophthalmology in Movement Disorders

from Section 1: - Basic Introduction

Published online by Cambridge University Press:  07 January 2025

By
Grace F. Crotty  and
Bart K. Chwalisz
Edited by
Erik Ch. Wolters  and
Christian R. Baumann
Erik Ch. Wolters
Affiliation:
Universität Zürich
Christian R. Baumann
Affiliation:
Universität Zürich
Get access

Summary

In this chapter, we review the neuro-ophthalmologic history and examination, and provide frameworks for their assessment. We summarize the neuro-ophthalmologic manifestations in common movement disorders. Attention to the neuro-ophthalmologic system can assist with the differential diagnosis of these conditions.

Keywords

ophthalmologyneuro-ophthalmologymovement disorderssaccadespursuits
Type
Chapter
Information
International Compendium of Movement Disorders , pp. 122 - 131
Publisher: Cambridge University Press
Print publication year: 2025

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Tysnes, OB, Storstein, A. Epidemiology of Parkinson’s disease. J Neural Transm Vienna 2017;124(8):901–905.CrossRefGoogle ScholarPubMed
Gibb, WR, Lees, AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 1988;51(6):745–752.CrossRefGoogle Scholar
Hamedani, AG, Abraham, DS, Maguire, MG, Willis, AW. Visual impairment is more common in Parkinson’s disease and is a risk factor for poor health outcomes. Mov Disord 2020;35(9):1542–1549.CrossRefGoogle ScholarPubMed
Han, G, Han, J, Han, K, Youn, J, Chung, TY, Lim, DH. Visual acuity and development of Parkinson’s disease: a nationwide cohort study. Mov Disord 2020;35(9):1532–1541.CrossRefGoogle ScholarPubMed
Price, MJ, Feldman, RG, Adelberg, D, Kayne, H. Abnormalities in color vision and contrast sensitivity in Parkinson’s disease. Neurology 1992;42(4):887–890.CrossRefGoogle ScholarPubMed
Weil, RS, Schrag, AE, Warren, JD, et al. Visual dysfunction in Parkinson’s disease. Brain J Neurol 2016;139(11):2827–2843.CrossRefGoogle ScholarPubMed
Büttner, T, Kuhn, W, Klotz, P, et al. Disturbance of colour perception in Parkinson’s disease. J Neural Transm Park Dis Dement Sect 1993;6(1):11–15.CrossRefGoogle ScholarPubMed
Rieger, G. Improvement of contrast sensitivity with yellow filter glasses. Can J Ophthalmol 1992;27(3):137–138.Google ScholarPubMed
Almer, Z, Klein, KS, Marsh, L, Gerstenhaber, M, Repka, MX. Ocular motor and sensory function in Parkinson’s disease. Ophthalmology 2012;119(1):178–182.CrossRefGoogle ScholarPubMed
Büttner, T, Kuhn, W, Patzold, T, Przuntek, H. L-Dopa improves colour vision in Parkinson’s disease. J Neural Transm Park Dis Dement Sect 1994;7(1):13–19.CrossRefGoogle ScholarPubMed
Nakamura, T, Kanayama, R, Sano, R, et al. Quantitative analysis of ocular movements in Parkinson’s disease. Acta Oto-Laryngol Suppl 1991;481:559–562.CrossRefGoogle ScholarPubMed
Corin, MS, Elizan, TS, Bender, MB. Oculomotor function in patients with Parkinson’s disease. J Neurol Sci 1972;15(3):251–265.CrossRefGoogle ScholarPubMed
Shibasaki, H, Tsuji, S, Kuroiwa, Y. Oculomotor abnormalities in Parkinson’s disease. Arch Neurol 1979;36(6):360–364.CrossRefGoogle ScholarPubMed
Ladda, J, Valkovic, P, Eggert, T, Straube, A. Parkinsonian patients show impaired predictive smooth pursuit. J Neurol 2008;255(7):1071–1078.CrossRefGoogle ScholarPubMed
Vidailhet, M, Rivaud, S, Gouider-Khouja, N, et al. Eye movements in parkinsonian syndromes. Ann Neurol 1994;35(4):420–426.CrossRefGoogle ScholarPubMed
Pinkhardt, EH, Kassubek, J, Süssmuth, S, et al. Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson’s disease. J Neurol 2009;256(9):1438–1446.CrossRefGoogle ScholarPubMed
Kassavetis, P, Kaski, D, Anderson, T, Hallett, M. Eye movement disorders in movement disorders. Mov Disord Clin Pract 2022;9(3):284–295.CrossRefGoogle ScholarPubMed
Shaunak, S, O’Sullivan, E, Blunt, S, et al. Remembered saccades with variable delay in Parkinson’s disease. Mov Disord 1999;14(1):80–86.3.0.CO;2-M>CrossRefGoogle ScholarPubMed
Briand, KA, Strallow, D, Hening, W, Poizner, H, Sereno, AB. Control of voluntary and reflexive saccades in Parkinson’s disease. Exp Brain Res 1999;129(1):38–48.CrossRefGoogle ScholarPubMed
Antoniades, CA, Demeyere, N, Kennard, C, Humphreys, GW, Hu, MT. Antisaccades and executive dysfunction in early drug-naive Parkinson’s disease: the discovery study. Mov Disord 2015;30(6):843–847.CrossRefGoogle ScholarPubMed
Urwyler, P, Nef, T, Killen, A, et al. Visual complaints and visual hallucinations in Parkinson’s disease. Parkinsonism Relat Disord 2014;20(3):318–322.CrossRefGoogle ScholarPubMed
Lin, IC, Wang, YH, Wang, TJ, et al. Glaucoma, Alzheimer’s disease, and Parkinson’s disease: an 8-year population-based follow-up study. PLoS One 2014;9(9):e108938.CrossRefGoogle ScholarPubMed
Lai, SW, Lin, CL, Liao, KF. Glaucoma correlates with increased risk of Parkinson’s disease in the elderly: a national-based cohort study in Taiwan. Curr Med Res Opin 2017;33(8):1511–1516.CrossRefGoogle ScholarPubMed
Kawabata, K, Ohdake, R, Watanabe, H, et al. Visuoperceptual disturbances in Parkinson’s disease. Clin Park Relat Disord 2020;3:100036.Google ScholarPubMed
Schrag, A, Ben-Shlomo, Y, Quinn, NP. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 1999;354(9192):1771–1775.CrossRefGoogle ScholarPubMed
Gilman, S, Wenning, GK, Low, PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71(9):670–676.CrossRefGoogle ScholarPubMed
Hughes, AJ, Ben-Shlomo, Y, Daniel, SE, Lees, AJ. What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. Neurology 1992;42(6):1142–1146.CrossRefGoogle ScholarPubMed
Armstrong, RA. Visual signs and symptoms of multiple system atrophy. Clin Exp Optom 2014;97(6):483–491.CrossRefGoogle ScholarPubMed
Sartucci, F, Orlandi, G, Bonuccelli, U, et al. Chromatic pattern-reversal electroretinograms (ChPERGs) are spared in multiple system atrophy compared with Parkinson’s disease. Neurol Sci 2006;26(6):395–401.CrossRefGoogle ScholarPubMed
Anderson, T, Luxon, L, Quinn, N, et al. Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients. Mov Disord 2008;23(7):977–984.CrossRefGoogle ScholarPubMed
Brooks, SH, Klier, EM, Red, SD, et al. Slowed prosaccades and increased antisaccade errors as a potential behavioral biomarker of multiple system atrophy. Front Neurol 2017;8:261.CrossRefGoogle ScholarPubMed
Bertram, K, Williams, DR. Visual hallucinations in the differential diagnosis of parkinsonism. J Neurol Neurosurg Psychiatry 2012;83(4):448–452.CrossRefGoogle ScholarPubMed
McKeith, IG, Boeve, BF, Dickson, DW, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 2017;89(1):88–100.CrossRefGoogle ScholarPubMed
Unger, RH, Flanigan, PM, Khosravi, M, Leverenz, JB, Tousi, B. Clinical and imaging characteristics associated with color vision impairment in Lewy body disease. J Alzheimers Dis 2019;72(4):1233–1240.CrossRefGoogle ScholarPubMed
Anderson, TJ, MacAskill, MR. Eye movements in patients with neurodegenerative disorders. Nat Rev Neurol 2013;9(2):74–85.CrossRefGoogle ScholarPubMed
Viscidi, E, Litvan, I, Dam, T, et al. Clinical features of patients with progressive supranuclear palsy in a US insurance claims database. Front Neurol 2021;12:571800.CrossRefGoogle Scholar
Hoglinger, GU, Respondek, G, Stamelou, M, et al. Clinical diagnosis of progressive supranuclear palsy: the Movement Disorder Society criteria. Mov Disord 2017;32(6):853–864.CrossRefGoogle ScholarPubMed
Armstrong, RA. Visual signs and symptoms of progressive supranuclear palsy. Clin Exp Optom 2011;94(2):150–160.CrossRefGoogle ScholarPubMed
Matsumoto, H, Inaba, T, Kakumoto, T, et al. Progressive supranuclear palsy with wall-eyed bilateral internuclear ophthalmoplegia syndrome: authors’ second case. Case Rep Neurol 2019;11(2):205–208.CrossRefGoogle ScholarPubMed
Otero-Millan, J, Serra, A, Leigh, RJ, et al. Distinctive features of saccadic intrusions and microsaccades in progressive supranuclear palsy. J Neurosci 2011;31(12):4379–4387.CrossRefGoogle ScholarPubMed
Pinkhardt, EH, Jürgens, R, Becker, W, et al. Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson’s syndrome, and idiopathic Parkinson’s disease. J Neurol 2008;255(12):1916–1925.CrossRefGoogle ScholarPubMed
Quinn, N. The “round the houses” sign in progressive supranuclear palsy. Ann Neurol 1996;40(6):951.CrossRefGoogle Scholar
Abate, F, Picillo, M, Della Rocca, G, Barone, P, Erro, R. The “zig-zag” sign in progressive supranuclear palsy. Parkinsonism Relat Disord 2020;79:86–87.CrossRefGoogle Scholar
Chen, AL, Riley, DE, King, SA, et al. The disturbance of gaze in progressive supranuclear palsy: implications for pathogenesis. Front Neurol 2010;1:147.CrossRefGoogle ScholarPubMed
Hardwick, A, Rucker, JC, Cohen, ML, et al. Evolution of oculomotor and clinical findings in autopsy-proven Richardson syndrome. Neurology 2009;73(24):2122–2124.CrossRefGoogle ScholarPubMed
Garbutt, S, Riley, DE, Kumar, AN, et al. Abnormalities of optokinetic nystagmus in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2004;75(10):1386–1394.CrossRefGoogle ScholarPubMed
Constantinides, VC, Paraskevas, GP, Paraskevas, PG, Stefanis, L, Kapaki, E. Corticobasal degeneration and corticobasal syndrome: a review. Clin Park Relat Disord 2019;1:66–71.Google ScholarPubMed
Armstrong, MJ, Litvan, I, Lang, AE, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 2013;80(5):496–503.CrossRefGoogle ScholarPubMed
Rivaud-Péchoux, S, Vidailhet, M, Gallouedec, G, et al. Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology 2000;54(5):1029–1032.CrossRefGoogle ScholarPubMed
Rajagopal, R, Bateman, R, Van Stavern, GP. Visual involvement in corticobasal syndrome. J Neuro-Ophthalmol 2012;32(4):338–340.CrossRefGoogle ScholarPubMed
Song, P, Zhang, Y, Zha, M, et al. The global prevalence of essential tremor, with emphasis on age and sex: a meta-analysis. J Glob Health 2021;11:04028.CrossRefGoogle ScholarPubMed
Bhatia, KP, Bain, P, Bajaj, N, et al. Consensus statement on the classification of tremors from the Task Force on Tremor of the International Parkinson and Movement Disorder Society. Mov Disord 2018;33(1):75–87.CrossRefGoogle ScholarPubMed
Helmchen, C, Hagenow, A, Miesner, J, et al. Eye movement abnormalities in essential tremor may indicate cerebellar dysfunction. Brain J Neurol 2003;126(Pt 6):1319–1332.CrossRefGoogle ScholarPubMed
Visser, F, Bour, LJ, Lee, YX, Ten Brinke, TR, van Rootselaar, AF. Eye movement abnormalities in essential tremor versus tremor dominant Parkinson’s disease. Clin Neurophysiol 2019;130(5):683–691.CrossRefGoogle ScholarPubMed
Gitchel, GT, Wetzel, PA, Baron, MS. Slowed saccades and increased square wave jerks in essential tremor. Tremor Other Hyperkinetic Mov N Y 2013;3:tre-03-178-4116-2.Google ScholarPubMed
Louis, ED, Gerbin, M, Viner, AS. Color vision: a study of essential tremor cases versus normal controls. Eur J Neurol 2012;19(8):1136–1139.CrossRefGoogle ScholarPubMed
Oh, YS, Kim, JS, Chung, SW, et al. Color vision in Parkinson’s disease and essential tremor. Eur J Neurol 2011;18(4):577–583.CrossRefGoogle ScholarPubMed
Paulson, HL, Shakkottai, VG, Clark, HB, Orr, HT. Polyglutamine spinocerebellar ataxias – from genes to potential treatments. Nat Rev Neurosci 2017;18(10):613–626.CrossRefGoogle ScholarPubMed
Teive, HAG, Munhoz, RP, Arruda, WO, et al. Spinocerebellar ataxias: genotype–phenotype correlations in 104 Brazilian families. Clinics (Sao Paulo) 2012;67(5):443–449.CrossRefGoogle ScholarPubMed
Rosini, F, Pretegiani, E, Battisti, C, et al. Eye movement changes in autosomal dominant spinocerebellar ataxias. Neurol Sci 2020;41(7):1719–1734.CrossRefGoogle ScholarPubMed
Yabe, I, Sasaki, H, Takeichi, N, et al. Positional vertigo and macroscopic downbeat positioning nystagmus in spinocerebellar ataxia type 6 (SCA6). J Neurol 2003;250(4):440–443.CrossRefGoogle ScholarPubMed
Moscovich, M, Okun, MS, Favilla, C, et al. Clinical evaluation of eye movements in spinocerebellar ataxias: a prospective multicenter study. J Neuro-Ophthalmol 2015;35(1):16–21.CrossRefGoogle ScholarPubMed
Miller, RC, Tewari, A, Miller, JA, Garbern, J, Van Stavern, GP. Neuro-ophthalmologic features of spinocerebellar ataxia type 7. J Neuro-Ophthalmol 2009;29(3):180–186.CrossRefGoogle ScholarPubMed
Dupré, M, Hermann, R, Froment Tilikete, C. Update on cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS). Cerebellum 2021;20(5):687–700.CrossRefGoogle ScholarPubMed
Swift, M, Morrell, D, Cromartie, E, et al. The incidence and gene frequency of ataxia–telangiectasia in the United States. Am J Hum Genet 1986;39(5):573–583.Google ScholarPubMed
Boder, E, Sedgwick, RP. Ataxia–telangiectasia; a familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection. Pediatrics 1958;21(4):526–554.CrossRefGoogle ScholarPubMed
Lewis, RF, Lederman, HM, Crawford, TO. Ocular motor abnormalities in ataxia telangiectasia. Ann Neurol 1999;46(3):287–295.3.0.CO;2-0>CrossRefGoogle ScholarPubMed
Farr, AK, Shalev, B, Crawford, TO, et al. Ocular manifestations of ataxia–telangiectasia. Am J Ophthalmol 2002;134(6):891–896.CrossRefGoogle ScholarPubMed
Hirsig, A, Barbey, C, Schüpbach, MWM, Bargiotas, P. Oculomotor functions in focal dystonias: a systematic review. Acta Neurol Scand 2020;141(5):359–367.CrossRefGoogle ScholarPubMed
Barow, E, Schneider, SA, Bhatia, KP, Ganos, C. Oculogyric crises: etiology, pathophysiology and therapeutic approaches. Parkinsonism Relat Disord 2017;36:3–9.CrossRefGoogle ScholarPubMed
Onuaguluchi, G. Crises in post-encephalitic Parkinsonism. Brain 1961;84:395–414.CrossRefGoogle ScholarPubMed
Di Maio, L, Squitieri, F, Napolitano, G, et al. Onset symptoms in 510 patients with Huntington’s disease. J Med Genet 1993;30(4):289–292.CrossRefGoogle ScholarPubMed
Blekher, T, Johnson, SA, Marshall, J, et al. Saccades in presymptomatic and early stages of Huntington disease. Neurology 2006;67(3):394–399.CrossRefGoogle ScholarPubMed
Fielding, J, Georgiou-Karistianis, N, Bradshaw, J, et al. Impaired modulation of the vestibulo-ocular reflex in Huntington’s disease. Mov Disord 2004;19(1):68–75.CrossRefGoogle ScholarPubMed
Leigh, RJ, Newman, SA, Folstein, SE, Lasker, AG, Jensen, BA. Abnormal ocular motor control in Huntington’s disease. Neurology 1983;33(10):1268–1275.CrossRefGoogle ScholarPubMed
Robertson, MM. A personal 35 year perspective on Gilles de la Tourette syndrome: prevalence, phenomenology, comorbidities, and coexistent psychopathologies. Lancet Psychiatry 2015;2(1):68–87.CrossRefGoogle ScholarPubMed
Straube, A, Mennicken, JB, Riedel, M, Eggert, T, Müller, N. Saccades in Gilles de la Tourette’s syndrome. Mov Disord 1997;12(4):536–546.CrossRefGoogle ScholarPubMed
Farber, R, Swerdlow, N, Clementz, B. Saccadic performance characteristics and the behavioural neurology of Tourette’s syndrome. J Neurol Neurosurg Psychiatry 1999;66(3):305–312.CrossRefGoogle ScholarPubMed
Goetz, CG. Eye signs and tic disorders: Gilles de la Tourette’s syndrome. J Am Optom Assoc 1997;68(11):688–692.Google ScholarPubMed
Bisker, ER, McClelland, CM, Brown, LW, Liu, GT. The long-term outcomes of ocular tics in a pediatric neuro-ophthalmology practice. J AAPOS 2014;18(1):31–35.CrossRefGoogle Scholar
Enoch, JM, Itzhaki, A, Lakshminarayanan, V, Comerford, JP, Lieberman, M. Visual field defects detected in patients with Gilles de la Tourette syndrome: preliminary report. Int Ophthalmol 1989;13(5):331–344.CrossRefGoogle ScholarPubMed
Baizabal-Carvallo, JF, Jankovic, J. Psychogenic ophthalmologic movement disorders. J Neuropsychiatry Clin Neurosci 2016;28(3):195–198.CrossRefGoogle ScholarPubMed
Kaski, D, Bronstein, AM, Edwards, MJ, Stone, J. Cranial functional (psychogenic) movement disorders. Lancet Neurol 2015;14(12):1196–1205.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×